Literature DB >> 13053428

The metabolic fate of 5-(1-cyclohexen-1-yl)-1, 5-dimethyl barbituric acid (hexobarbital, evipal) and of 5-(1-cyclohexen-1-yl)-5-methyl barbituric acid ("nor-evipal").

M T BUSH, T C BUTLER, H L DICKISON.   

Abstract

Entities:  

Keywords:  BARBITURATES/metabolism

Mesh：

Substances：

Year:  1953        PMID： 13053428

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  4 in total

1.  [Acceleration of oxidation of drugs during and after treatment with luminal].

Authors:  H REMMER; M SIEGERT; H W LIEBENSCHUETZ
Journal:  Klin Wochenschr       Date:  1961-05-01

2.  [Intravital & postmortem reduction of barbitals].

Authors:  G SCHMIDT
Journal:  Arch Toxikol       Date:  1958

3.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

4.  The effects of oestrogens and progestins on the response of mice to barbiturates.

Authors:  A Blackham; P S Spencer
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.